{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T09:28:44Z","timestamp":1700386124184},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,12,29]],"date-time":"2013-12-29T00:00:00Z","timestamp":1388275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00296-013-2931-9","type":"journal-article","created":{"date-parts":[[2013,12,28]],"date-time":"2013-12-28T02:38:09Z","timestamp":1388198289000},"page":"979-986","source":"Crossref","is-referenced-by-count":5,"title":["Thoughts and perceptions of ankylosing spondylitis patients with regard to TNF inhibitors"],"prefix":"10.1007","volume":"34","author":[{"given":"Fatma Ilknur","family":"Cinar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammet","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedat","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"Pay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,29]]},"reference":[{"key":"2931_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/msc.1029","volume":"11","author":"W Farren","year":"2013","unstructured":"Farren W, Goodacre L, Stigant M (2013) Fatigue in ankylosing spondylitis: causes, consequences and self-management. Musculoskelet Care 11:39\u201350","journal-title":"Musculoskelet Care"},{"key":"2931_CR2","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/ard.2004.022582","volume":"64","author":"H Marzo-Ortega","year":"2005","unstructured":"Marzo-Ortega H, McGonagle D, Jarrett S, Haugeberg G, Hensor E, O\u2019Connor P, Tan AL, Conaghan PG, Greenstein A, Emery P (2005) Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study. Ann Rheum Dis 64:1568\u20131575","journal-title":"Ann Rheum Dis"},{"key":"2931_CR3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00296-010-1616-x","volume":"32","author":"I Ertenli","year":"2012","unstructured":"Ertenli I, Ozer S, Kiraz S, Apras SB, Akdogan A, Karadag O, Calguneri M, Kalyoncu U (2012) Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Rheumatol Int 32:323\u2013330","journal-title":"Rheumatol Int"},{"key":"2931_CR4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/msc.146","volume":"7","author":"J Stockdale","year":"2009","unstructured":"Stockdale J, Goodacre L (2009) \u2018It\u2019s magic stuff\u2019: the experiences of patients with ankylosing spondylitis taking anti-TNF-alpha medication. Musculoskelet Care 7:162\u2013177","journal-title":"Musculoskelet Care"},{"key":"2931_CR5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.2010.139667","volume":"70","author":"IH Song","year":"2011","unstructured":"Song IH, Hermann K, Haibel H, Althoff CE, Listing J, Burmester G, Krause A, Bohl-Buhler M, Freundlich B, Rudwaleit M et al (2011) Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis 70:590\u2013596","journal-title":"Ann Rheum Dis"},{"key":"2931_CR6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3899\/jrheum.081048","volume":"36","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Claudepierre P, Wordsworth P, Cortina EL, Sieper J, Kron M, Carcereri-De-Prati R, Kupper H, Kary S (2009) Effectiveness, safety, and predictors of good clinical response in 1,250 patients treated with adalimumab for active ankylosing spondylitis. J Rheumatol 36:801\u2013808","journal-title":"J Rheumatol"},{"key":"2931_CR7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/art.24408","volume":"60","author":"N Barkham","year":"2009","unstructured":"Barkham N, Keen HI, Coates LC, O\u2019Connor P, Hensor E, Fraser AD, Cawkwell LS, Bennett A, McGonagle D, Emery P (2009) Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthr Rheum 60:946\u2013954","journal-title":"Arthr Rheum"},{"key":"2931_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/ard.2004.025130","volume":"64","author":"J Braun","year":"2005","unstructured":"Braun J, Brandt J, Listing J, Zink A, Alten R, Burmester G, Gromnica-Ihle E, Kellner H, Schneider M, Sorensen H et al (2005) Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Ann Rheum Dis 64:229\u2013234","journal-title":"Ann Rheum Dis"},{"key":"2931_CR9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/ard.62.9.817","volume":"62","author":"J Braun","year":"2003","unstructured":"Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, van der Heijde D (2003) International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62:817\u2013824","journal-title":"Ann Rheum Dis"},{"key":"2931_CR10","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/ard.2004.020875","volume":"63","author":"A Calin","year":"2004","unstructured":"Calin A, Dijkmans BA, Emery P, Hakala M, Kalden J, Leirisalo-Repo M, Mola EM, Salvarani C, Sanmarti R, Sany J, van der Linden S, Veys E, Appel AM, Fatenejad S (2004) Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis 63:1594\u20131600","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2931_CR11","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2004.029900","volume":"64","author":"SN Nikas","year":"2005","unstructured":"Nikas SN, Alamanos Y, Voulgari PV, Pliakou XI, Papadopoulos CG, Drosos AA (2005) Infliximab treatment in ankylosing spondylitis: an observational study. Ann Rheum Dis 64(6):940\u2013942","journal-title":"Ann Rheum Dis"},{"key":"2931_CR12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.20852","volume":"52","author":"D Heijde van der","year":"2005","unstructured":"van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthr Rheum 52:582\u2013591","journal-title":"Arthr Rheum"},{"key":"2931_CR13","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.22579","volume":"56","author":"F Wolfe","year":"2007","unstructured":"Wolfe F, Michaud K (2007) The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthr Rheum 56:1433\u20131439","journal-title":"Arthr Rheum"},{"key":"2931_CR14","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/art.22864","volume":"56","author":"F Wolfe","year":"2007","unstructured":"Wolfe F, Michaud K (2007) Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthr Rheum 56:2886\u20132895","journal-title":"Arthr Rheum"},{"key":"2931_CR15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261\u20131265","journal-title":"Clin Infect Dis"},{"key":"2931_CR16","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/rheumatology\/kel115","volume":"45","author":"J Martindale","year":"2006","unstructured":"Martindale J, Smith J, Sutton CJ, Grennan D, Goodacre L, Goodacre JA (2006) Disease and psychological status in ankylosing spondylitis. Rheumatology (Oxford) 45:1288\u20131293","journal-title":"Rheumatology (Oxford)"},{"key":"2931_CR17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00296-010-1381-x","volume":"31","author":"O Baysal","year":"2011","unstructured":"Baysal O, Durmus B, Ersoy Y, Altay Z, Senel K, Nas K, Ugur M, Kaya A, Gur A, Erdal A, Ard\u0131\u00e7o\u011flu O, Tekeo\u011flu I, Cevik R, Y\u0131ld\u0131r\u0131m K, Kamanl\u0131 A, Sara\u00e7 AJ, Karatay S, Ozgocmen S (2011) Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheum Int 31:795\u2013800","journal-title":"Rheum Int"},{"key":"2931_CR18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/art.11197","volume":"49","author":"R Ariza-Ariza","year":"2003","unstructured":"Ariza-Ariza R, Hernandez-Cruz B, Navarro-Sarabia F (2003) Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthr Rheum 49:483\u2013487","journal-title":"Arthr Rheum"},{"key":"2931_CR19","first-page":"277","volume":"10","author":"Y Braun-Moscovici","year":"2008","unstructured":"Braun-Moscovici Y, Markovits D, Rozin A, Toledano K, Nahir AM, Balbir-Gurman A (2008) Anti-tumor necrosis factor therapy: 6\u00a0year experience of a single center in northern Israel and possible impact of health policy on results. Isr Med Assoc J 10:277\u2013281","journal-title":"Isr Med Assoc J"},{"key":"2931_CR20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthr Rheum 27:361\u2013368","journal-title":"Arthr Rheum"},{"key":"2931_CR21","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheum 21:2286\u20132291","journal-title":"J Rheum"},{"key":"2931_CR22","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheum 21:2281\u20132285","journal-title":"J Rheum"},{"key":"2931_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/msc.55","volume":"2","author":"J Edwards","year":"2004","unstructured":"Edwards J (2004) An exploration of patients\u2019 experiences of anti-TNF therapy. Musculoskelet Care 2:40\u201350","journal-title":"Musculoskelet Care"},{"key":"2931_CR24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/msc.149","volume":"7","author":"T Sanderson","year":"2009","unstructured":"Sanderson T, Calnan M, Morris M, Richards P, Hewlett S (2009) The impact of patient-perceived restricted access to anti-TNF therapy for rheumatoid arthritis: a qualitative study. Musculoskelet Care 7:194\u2013209","journal-title":"Musculoskelet Care"},{"key":"2931_CR25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.berh.2004.03.008","volume":"18","author":"L Schrieber","year":"2004","unstructured":"Schrieber L, Colley M (2004) Patient education. Best Pract Res Clin Rheumatol 18:465\u2013476","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2931_CR26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2648.2003.02779.x","volume":"44","author":"LM Frich","year":"2003","unstructured":"Frich LM (2003) Nursing interventions for patients with chronic conditions. J Adv Nurs 44:137\u2013153","journal-title":"J Adv Nurs"},{"key":"2931_CR27","first-page":"10","volume":"16","author":"S Pehlivan","year":"2010","unstructured":"Pehlivan S, Ovayolu \u00d6, Ovayolu N, Pehlivan Y, Onat AM (2010) Romatolojik sorunu olan hastalarda ya\u015fam kalitesi ve baz\u0131 semptomlarla ili\u015fkisi. Gaziantep Med J 16:10\u201314","journal-title":"Gaziantep Med J"},{"key":"2931_CR28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pec.2011.07.020","volume":"87","author":"MH Eckman","year":"2012","unstructured":"Eckman MH, Wise R, Leonard AC, Dixon E, Burrows C, Khan F, Warm E (2012) Impact of health literacy on outcomes and effectiveness of an educational intervention in patients with chronic diseases. Patient Educ Couns 87:143\u2013151","journal-title":"Patient Educ Couns"},{"key":"2931_CR29","first-page":"104","volume":"48","author":"K Nair","year":"2002","unstructured":"Nair K, Dolovich L, Cassels A, McCormack J, Levine M, Gray J, Mann K, Burns S (2002) What patients want to know about their medications. Focus group study of patient and clinician perspectives. Can Fam Physician 48:104\u2013110","journal-title":"Can Fam Physician"},{"key":"2931_CR30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5455\/gulhane.39854","volume":"55","author":"FI Cinar","year":"2013","unstructured":"Cinar FI, Tosun N, Akbayrak N, Simsek I, Cinar M, Erdem H, Pay S, Kilic S, Yilmaz S, Cetinkaya S, Dinc A (2013) Comparison of the efficacy of written information vs. verbal plus written information in rheumatic patients who receive colchicine treatment. Gulhane Med J 55:94\u2013100","journal-title":"Gulhane Med J"},{"key":"2931_CR31","first-page":"185","volume":"28","author":"ME Suarez-Almazor","year":"2001","unstructured":"Suarez-Almazor ME, Kendall CJ, Dorgan M (2001) Surfing the Net\u2013information on the World Wide Web for persons with arthritis: patient empowerment or patient deceit? J Rheumatol 28:185\u2013191","journal-title":"J Rheumatol"},{"key":"2931_CR32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.20910","volume":"53","author":"H Dagfinrud","year":"2005","unstructured":"Dagfinrud H, Vollestad NK, Loge JH, Kvien TK, Mengshoel AM (2005) Fatigue in patients with ankylosing spondylitis: A comparison with the general population and associations with clinical and self-reported measures. Arthr Rheum 53:5\u201311","journal-title":"Arthr Rheum"},{"key":"2931_CR33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jbspin.2007.06.021","volume":"75","author":"EK Gunal","year":"2008","unstructured":"Gunal EK, Sarvan FO, Kamali S, Gul A, Inanc M, Carin M, Konice M, Aral O, Ocal L (2008) Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey. Jt Bone Spine 75:299\u2013302","journal-title":"Jt Bone Spine"},{"key":"2931_CR34","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1007\/s00296-013-2824-y","volume":"33","author":"M Cinar","year":"2013","unstructured":"Cinar M, Akar H, Yilmaz S, Simsek I, Karkucak M, Sagkan RI, Pekel A, Erdem H, Avci IY, Acikel C, Musabak U, Tunca Y, Pay S (2013) A polymorphism in ERAP1 is associated with susceptibility to ankylosing spondylitis in a Turkish population. Rheumatol Int 33:2851\u20132858","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2931-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2931-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2931-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:50Z","timestamp":1559028110000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2931-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,29]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["2931"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2931-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,29]]}}}